Comprehensive analysis of immune infiltration and gene expression for predicting survival in patients with sarcomas

Tumor microenvironments are strongly related to tumor development, and immune-infiltrating cells and immune-related molecules are potential prognostic markers. However, the shortcomings of traditional measurement methods limit the accurate evaluation of various components in tumor microenvironments. With the rapid advancement of Next-Generation RNA Sequencing technology, dedicated and in-depth analyses of immune filtration within the tumor microenvironment has been achieved. In this study, we combined the bioinformatics analysis methods ESTIMATE, CIBERSORT, and ssGSEA to characterize the immune infiltration of sarcomas and to identify specific immunomodulators of different pathological subtypes. We further extracted a functional enrichment of significant immune-related genes related to improved prognosis, including NR1H3, VAMP5, GIMAP2, GBP2, HLA-E and CRIP1. Overall, the immune microenvironment is an important prognostic determinant of sarcomas and may be a potential resource for developing effective immunotherapy.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Aging - 13(2020), 2 vom: 09. Dez., Seite 2168-2183

Sprache:

Englisch

Beteiligte Personen:

Chen, Hongmin [VerfasserIn]
Song, Yijiang [VerfasserIn]
Deng, Chuangzhong [VerfasserIn]
Xu, Yanyang [VerfasserIn]
Xu, Huaiyuan [VerfasserIn]
Zhu, Xiaojun [VerfasserIn]
Song, Guohui [VerfasserIn]
Tang, Qinglian [VerfasserIn]
Lu, Jinchang [VerfasserIn]
Wang, Jin [VerfasserIn]

Links:

Volltext

Themen:

Biomarkers, Tumor
CRIP1 protein, human
Carrier Proteins
EC 3.6.1.-
GBP2 protein, human
GIMAP2 protein, human
GTP Phosphohydrolases
GTP-Binding Proteins
Histocompatibility Antigens Class I
Immune checkpoint
Journal Article
LIM Domain Proteins
Liver X Receptors
Membrane Proteins
R-SNARE Proteins
Research Support, Non-U.S. Gov't
Sarcoma
Tumor-infiltrating immune cells
VAMP5 protein, human

Anmerkungen:

Date Completed 10.05.2021

Date Revised 13.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.18632/aging.202229

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM318820064